Early Phase 1 Recurrent Glioblastoma Clinical Trials
7 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–7 of 7 trials
Recruiting
Early Phase 1
Dosimetry, Safety, and Efficacy Study of [177Lu]Lu-XT771 in Patients With Recurrent Glioblastoma
Recurrent Glioblastoma, IDH-WildtypeGlioblastoma (GBM)Recurrent Glioblastoma+1 more
Beijing Tiantan Hospital5 enrolled2 locationsNCT07648823
Recruiting
Early Phase 1
Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma
Recurrent Glioblastoma
Huashan Hospital10 enrolled1 locationNCT07538128
Recruiting
Early Phase 1
Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
Recurrent GlioblastomaProgressive Glioblastoma
Mayo Clinic8 enrolled1 locationNCT07076472
Recruiting
Early Phase 1
Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma
GlioblastomaRecurrent GlioblastomaGlioblastoma Multiforme of Brain
Abramson Cancer Center at Penn Medicine15 enrolled2 locationsNCT06613841
Recruiting
Early Phase 1
A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
Brain TumorGlioblastomaRecurrent Glioblastoma
Ugonma Chukwueke27 enrolled3 locationsNCT06552260
Recruiting
Early Phase 1
Pilot Trial for Treatment of Recurrent Glioblastoma
GlioblastomaRecurrent GlioblastomaRecurrent Disease
AHS Cancer Control Alberta10 enrolled1 locationNCT05432518
Recruiting
Early Phase 1
Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma
Recurrent Glioblastoma
Oslo University Hospital15 enrolled1 locationNCT05043701